The latest closing stock price for Halozyme Therapeutics as of June 05, 2025 is 53.55.
An investor who bought $1,000 worth of Halozyme Therapeutics stock at the IPO in 2004 would have $11,904 today, roughly 12 times their original investment - a 12.95% compound annual growth rate over 21 years.
The all-time high Halozyme Therapeutics stock closing price was 70.14 on May 07, 2025.
The Halozyme Therapeutics 52-week high stock price is 70.51, which is 31.7% above the current share price.
The Halozyme Therapeutics 52-week low stock price is 42.01, which is 21.5% below the current share price.
The average Halozyme Therapeutics stock price for the last 52 weeks is 55.74.
An investor who bought $1,000 worth of Halozyme Therapeutics stock at the IPO in 2004 would have $11,904 today, roughly 12 times their original investment - a 12.95% compound annual growth rate over 21 years.
The all-time high Halozyme Therapeutics stock closing price was 70.14 on May 07, 2025.
The Halozyme Therapeutics 52-week high stock price is 70.51, which is 31.7% above the current share price.
The Halozyme Therapeutics 52-week low stock price is 42.01, which is 21.5% below the current share price.
The average Halozyme Therapeutics stock price for the last 52 weeks is 55.74.